IMS
IONS icon

Index Management Solutions’s Ionis Pharmaceuticals IONS Stock Holding History

Index Management Solutions’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$3K Buy
82
+8
+11% +$414 ﹤0.01% 674
2015
Q2 		$4K Sell
74
-132
-64% -$8.39K ﹤0.01% 713
2015
Q1 		$13K Buy
+206
New +$14K 0.01% 522

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Index Management Solutions's IONS Position: Q3 2015 in Review

Index Management Solutions increased its Ionis Pharmaceuticals (IONS) stake by 11% in Q3 2015, buying an estimated $414 and bringing the position to 82 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Index Management Solutions first reported a position in IONS in Q1 2015 and has held it in 3 quarters since. The position peaked at $13K in Q1 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

  • Index Management Solutions held 82 shares of Ionis Pharmaceuticals worth $3K as of Q3 2015.
  • Index Management Solutions bought 8 Ionis Pharmaceuticals shares in Q3 2015, an estimated $414.
  • Ionis Pharmaceuticals made up ﹤0.01% of Index Management Solutions's portfolio in Q3 2015, its #674 holding.
  • Index Management Solutions first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 3 quarters since.
  • Index Management Solutions's Ionis Pharmaceuticals position peaked at $13K in Q1 2015.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Index Management Solutions's 13F filing for Q3 2015, filed 13 Nov 2015.